Exploring the pH Sensitivity of Poly(allylamine) Phosphate Supramolecular Nanocarriers for Intracellular siRNA Delivery

被引:43
作者
Andreozzi, Patrizia [1 ]
Diamanti, Eleftheria [1 ]
Py-Daniel, Karen Rapp [2 ]
Caceres-Velez, Paolin Rocio [2 ]
Martinelli, Chiara [3 ]
Politakos, Nikolaos [1 ]
Escobar, Ane [1 ]
Muzi-Falconi, Marco [3 ]
Azevedo, Ricardo [2 ]
Moya, Sergio E. [1 ]
机构
[1] CIC biomaGUNE, Soft Matter Nanotechnol Grp, Paseo Miramon 182 C, San Sebastian 20014, Guipuzcoa, Spain
[2] Univ Brasilia, Inst Ciencias Biol, Dept Genet & Morfol, BR-70910900 Brasilia, DF, Brazil
[3] Univ Milan, Dept Biosci, Via Giovanni Celoria 26, I-20133 Milan, Italy
关键词
self-assembly; supramolecular nanocarriers; pH sensitive; drug delivery; siRNA; INTERFERING RNA DELIVERY; CANCER-THERAPY; DRUG-DELIVERY; GENE DELIVERY; TRANSFECTION EFFICIENCY; MEDIATED DELIVERY; THIN-FILMS; IN-VIVO; NANOPARTICLES; THERAPEUTICS;
D O I
10.1021/acsami.7b11132
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Silencing RNA (siRNA) technologies emerge as a promising therapeutic tool for the treatment of multiple diseases. An ideal nanocarrier (NC) for siRNAs should be stable at physiological pH and release siRNAs in acidic endosomal pH, fulfilling siRNA delivery only inside cells. Here, we show a novel application of polyamine phosphate NCs (PANs) based on their capacity to load negatively charged nucleic acids and their pH stability. PANs are fabricated by complexation of phosphate anions from phosphate buffer solution (PB) with the amine groups of poly(allylamine) hydrochloride as carriers for siRNAs. PANs are stable in a narrow pH interval, from 7 to 9, and disassemble at pH's higher than 9 and lower than 6. siRNAs are encapsulated by complexation with poly(allylamine) hydrochloride before or after PAN formation. PANs with encapsulated siRNAs are stable in cell media. Once internalized in cells following endocytic pathways, PANs disassemble at the low endosomal pH and release the siRNAs into the cytoplasm. Confocal laser scanning microscopy (CLSM) images of Rhodamine Green labeled PANs (RG-PANs) with encapsulated Cy3-labeled siRNA in A549 cells show that siRNAs are released from the PANs. Colocalization experiments with labeled endosomes and either labeled siRNAs prove the translocation of siRNAs into the cytosol. As a proof of concept, it is shown that PANs with encapsulated green fluorescence protein (GFP) siRNAs silence GFP in A549 cells expressing this protein. Silencing efficacy was evaluated by flow cytometry, CLSM, and Western blot assays. These results open the way for the use of poly(allylamine) phosphate nanocarriers for the intracellular delivery of genetic materials.
引用
收藏
页码:38242 / 38254
页数:13
相关论文
共 51 条
  • [1] Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation
    Akita, Hidetaka
    Kogure, Kentaro
    Moriguchi, Rumiko
    Nakamura, Yoshio
    Higashi, Tomoko
    Nakamura, Takashi
    Serada, Satoshi
    Fujimoto, Minoru
    Naka, Tetsuji
    Futaki, Shiroh
    Harashima, Hideyoshi
    [J]. JOURNAL OF CONTROLLED RELEASE, 2010, 143 (03) : 311 - 317
  • [2] Polyamine-salt aggregate assembly of capsules as responsive drug delivery vehicles
    Bagaria, Hitesh G.
    Wong, Michael S.
    [J]. JOURNAL OF MATERIALS CHEMISTRY, 2011, 21 (26) : 9454 - 9466
  • [3] Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy
    Biju, Vasudevanpillai
    [J]. CHEMICAL SOCIETY REVIEWS, 2014, 43 (03) : 744 - 764
  • [4] RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?
    Bobbin, Maggie L.
    Rossi, John J.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56, 2016, 56 : 103 - 122
  • [5] Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
    Chen, Sam
    Tam, Yuen Yi C.
    Lin, Paulo J. C.
    Sung, Molly M. H.
    Tam, Ying K.
    Cullis, Pieter R.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2016, 235 : 236 - 244
  • [6] A holistic approach to targeting disease with polymeric nanoparticles
    Cheng, Christopher J.
    Tietjen, Gregory T.
    Saucier-Sawyer, Jennifer K.
    Saltzman, W. Mark
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (04) : 239 - 247
  • [7] Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies
    Deng, Yan
    Wang, Chi Chiu
    Choy, Kwong Wai
    Du, Quan
    Chen, Jiao
    Wang, Qin
    Li, Lu
    Chung, Tony Kwok Hung
    Tang, Tao
    [J]. GENE, 2014, 538 (02) : 217 - 227
  • [8] Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
    Deng, Zhou J.
    Morton, Stephen W.
    Ben-Akiva, Elana
    Dreaden, Erik C.
    Shopsowitz, Kevin E.
    Hammond, Paula T.
    [J]. ACS NANO, 2013, 7 (11) : 9571 - 9584
  • [9] Nanoparticle-Mediated Systemic Delivery of siRNA for Treatment of Cancers and Viral Infections
    Draz, Mohamed Shehata
    Fang, Binbin Amanda
    Zhang, Pengfei
    Hu, Zhi
    Gu, Shenda
    Weng, Kevin C.
    Gray, Joe W.
    Chen, Fanqing Frank
    [J]. THERANOSTICS, 2014, 4 (09): : 872 - 892
  • [10] Polycationic Nanoparticles for siRNA Delivery: Comparing ARGET ATRP and UV-Initiated Formulations
    Forbes, Diane C.
    Peppas, Nicholas A.
    [J]. ACS NANO, 2014, 8 (03) : 2908 - 2917